News

Latest article

July 25, 2025

Celfex AB (Goteborg, Sweden) to engage Noah Therapeutics for Phase 2 Clinical Trial of Celfex – Topical Lotion for Atopic Dermatitis

Celfex AB is a wholly owned subsidiary of Swiss based MHG Management GmbH (‘MHG’). MHG is is partnered with NOAH Therapeutics (NOAH)

Past articles

March 7, 2025

Celfex AB (Goteborg, Sweden) enters into sub-license agreement with MHG Management GmbH (‘MHG’)

MHG Management GmbH has partnered with Cellix Biosciences Pte Ltd and entered into an agreement for development of CELFEX. MHG will provide management

Mahesh Kandula

Founder - Cellix Bioscience

Mahesh Kandula (founder of Cellix Biosciences) - "I am looking forward to see Celfex brought to market. I am confident in the potential to bring value to children around the world suffering from Atopic Dermatitis. I am happy that Celfex is taking action to untrap the value of fexofenadine for this purpose".